Tegatrabetan
Tegatrabetan (BC2059) is a small molecule Wnt/β-catenin pathway inhibitor investigated for its anticancer properties. It is utilized in oncology research to study aberrant Wnt signaling in various cancer models, demonstrating activity in both in vitro cellular assays and in vivo preclinical studies.
Product Specifications
CAS Number
1227637-23-1
Product Name Alternative
Inhibitor, inhibit, bcatenin, BC 2059, BC2059, BC-2059, betacatenin, beta-catenin, Beta catenin, Wnt/β-catenin, Wnt/betacatenin, Wnt/b-catenin, Wnt, Tegatrabetan, βcatenin, β-catenin
Field of Research
Signal Transduction, Stem Cell & Developmental Biology
Purity
98.00% (May vary between batches)
Solubility
DMSO:60 mg/mL (101.91 mM) ;10% DMSO+90% Corn Oil:2.5 mg/mL (4.25 mM)
Smiles
C[C@H]1C[C@@H] (C) CN (C1) S (=O) (=O) c1ccc2C (=NO) c3ccc (cc3C (=NO) c2c1) S (=O) (=O) N1C[C@@H] (C) C[C@@H] (C) C1
Molecular Formula
C28H36N4O6S2
Molecular Weight
588.74
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15261524 1 Vial
Lentiviral mouse Plxnb2 shRNA (UAS) - Lentiviral mousePlxnb2 shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details 